Corrigendum on “Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer” [Cancer Lett. 363 (1) (2015) 28–36](S0304383515002256)(10.1016/j.canlet.2015.03.033)

Kanjoormana A. Manu; Muthu K. Shanmugam; Lalitha Ramachandran; Feng Li; Kodappully Sivaraman Siveen; Arunachalam Chinnathambi; M. E. Zayed; Sulaiman Ali Alharbi; Frank Arfuso; Alan Prem Kumar; Kwang Seok Ahn; Gautam Sethi

doi:10.1016/j.canlet.2018.01.003

Corrigendum on “Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer” [Cancer Lett. 363 (1) (2015) 28–36](S0304383515002256)(10.1016/j.canlet.2015.03.033)

Kanjoormana A. Manu, Muthu K. Shanmugam, Lalitha Ramachandran, Feng Li, Kodappully Sivaraman Siveen, Arunachalam Chinnathambi, M. E. Zayed, Sulaiman Ali Alharbi, Frank Arfuso, Alan Prem Kumar, Kwang Seok Ahn, Gautam Sethi

Research output: Contribution to journal › Comment/debate

3 Citations (Scopus)

Abstract

The authors regret that there was a typographical error in the title of the article “Capeciatbine” should be spelled as “Capecitabine”. The authors would like to apologize for any inconvenience caused.

Original language	English
Pages (from-to)	259
Number of pages	1
Journal	Cancer Letters
Volume	420
DOIs	https://doi.org/10.1016/j.canlet.2018.01.003
Publication status	Published - 28 Apr 2018

Bibliographical note

Publisher Copyright:
© 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.canlet.2018.01.003

Fingerprint

Dive into the research topics of 'Corrigendum on “Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer” [Cancer Lett. 363 (1) (2015) 28–36](S0304383515002256)(10.1016/j.canlet.2015.03.033)'. Together they form a unique fingerprint.

Cite this

Manu, K. A., Shanmugam, M. K., Ramachandran, L., Li, F., Siveen, K. S., Chinnathambi, A., Zayed, M. E., Alharbi, S. A., Arfuso, F., Kumar, A. P., Ahn, K. S., & Sethi, G. (2018). Corrigendum on “Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer” [Cancer Lett. 363 (1) (2015) 28–36](S0304383515002256)(10.1016/j.canlet.2015.03.033). Cancer Letters, 420, 259. https://doi.org/10.1016/j.canlet.2018.01.003

@article{fb76476a9e934b1aaca31549f2ca802f,

title = "Corrigendum on “Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer” [Cancer Lett. 363 (1) (2015) 28–36](S0304383515002256)(10.1016/j.canlet.2015.03.033)",

abstract = "The authors regret that there was a typographical error in the title of the article “Capeciatbine” should be spelled as “Capecitabine”. The authors would like to apologize for any inconvenience caused.",

author = "Manu, {Kanjoormana A.} and Shanmugam, {Muthu K.} and Lalitha Ramachandran and Feng Li and Siveen, {Kodappully Sivaraman} and Arunachalam Chinnathambi and Zayed, {M. E.} and Alharbi, {Sulaiman Ali} and Frank Arfuso and Kumar, {Alan Prem} and Ahn, {Kwang Seok} and Gautam Sethi",

note = "Publisher Copyright: {\textcopyright} 2018",

year = "2018",

month = apr,

day = "28",

doi = "10.1016/j.canlet.2018.01.003",

language = "English",

volume = "420",

pages = "259",

journal = "Cancer Letters",

issn = "0304-3835",

publisher = "Elsevier Ireland Ltd",

}

Manu, KA, Shanmugam, MK, Ramachandran, L, Li, F, Siveen, KS, Chinnathambi, A, Zayed, ME, Alharbi, SA, Arfuso, F, Kumar, AP, Ahn, KS & Sethi, G 2018, 'Corrigendum on “Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer” [Cancer Lett. 363 (1) (2015) 28–36](S0304383515002256)(10.1016/j.canlet.2015.03.033)', Cancer Letters, vol. 420, pp. 259. https://doi.org/10.1016/j.canlet.2018.01.003

Corrigendum on “Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer” [Cancer Lett. 363 (1) (2015) 28–36](S0304383515002256)(10.1016/j.canlet.2015.03.033). / Manu, Kanjoormana A.; Shanmugam, Muthu K.; Ramachandran, Lalitha et al.
In: Cancer Letters, Vol. 420, 28.04.2018, p. 259.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Corrigendum on “Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer” [Cancer Lett. 363 (1) (2015) 28–36](S0304383515002256)(10.1016/j.canlet.2015.03.033)

AU - Manu, Kanjoormana A.

AU - Shanmugam, Muthu K.

AU - Ramachandran, Lalitha

AU - Li, Feng

AU - Siveen, Kodappully Sivaraman

AU - Chinnathambi, Arunachalam

AU - Zayed, M. E.

AU - Alharbi, Sulaiman Ali

AU - Arfuso, Frank

AU - Kumar, Alan Prem

AU - Ahn, Kwang Seok

AU - Sethi, Gautam

PY - 2018/4/28

Y1 - 2018/4/28

N2 - The authors regret that there was a typographical error in the title of the article “Capeciatbine” should be spelled as “Capecitabine”. The authors would like to apologize for any inconvenience caused.

AB - The authors regret that there was a typographical error in the title of the article “Capeciatbine” should be spelled as “Capecitabine”. The authors would like to apologize for any inconvenience caused.

UR - http://www.scopus.com/inward/record.url?scp=85042443738&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2018.01.003

DO - 10.1016/j.canlet.2018.01.003

M3 - Comment/debate

C2 - 29338890

AN - SCOPUS:85042443738

SN - 0304-3835

VL - 420

SP - 259

JO - Cancer Letters

JF - Cancer Letters

ER -

Manu KA, Shanmugam MK, Ramachandran L, Li F, Siveen KS, Chinnathambi A et al. Corrigendum on “Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer” [Cancer Lett. 363 (1) (2015) 28–36](S0304383515002256)(10.1016/j.canlet.2015.03.033). Cancer Letters. 2018 Apr 28;420:259. doi: 10.1016/j.canlet.2018.01.003

Corrigendum on “Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer” [Cancer Lett. 363 (1) (2015) 28–36](S0304383515002256)(10.1016/j.canlet.2015.03.033)

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this